Login / Signup

Efficacy and safety of secukinumab for the treatment of severe ABCA12 deficiency-related ichthyosis in a child.

J YogarajahC GouveiaJ IypeS HäfligerA SchallerJ M NuofferM FuxMatthias Gautschi
Published in: Skin health and disease (2021)
Further studies are needed to evaluate the effects of the use of IL-17A inhibition in ARCI patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • early onset
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • replacement therapy
  • drug induced
  • patient reported